Loading...

ALNY ALNYLAM PHARMACEUTICALS INC Management Changes 8-K Filing

LNYL

LNY

ALNYLAM PHARMACEUTICALS INC

(ALNY)

2025 8-K

Show Summary

Summary

Financial Statements

Board Retirement

Financial Results

Financial Results

Earnings Reports

Annual Meeting of Stockholders

Financial Results Announcement

Departure of Directors

Financial Results Announcement

Departure of Directors

Financial Results

Financial Results Announcement

FDA Complete Response Letter

Resignation of Director

Financial Results and Manag...

Collaboration and License A...

Annual Meeting of Stockholders

Financial Results Announcement

Board Expansion and New Dir...

Financial Results Announcement

Earnings Reports

Board Expansion and New Dir...

External Links:

Phillip A. Sharp, Ph.D. will retire from Alnylam Pharmaceuticals' Board on May 8, 2025, but will remain on the Scientific Advisory Board; his retirement is not due to any disagreements with the company. A press release about his retirement was issued on March 5, 2025.

AI Assistant

ALNYLAM PHARMACEUTICALS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.